Jane Street’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-61,021
| Closed | -$130K | – | 5529 |
|
2025
Q1 | $130K | Buy |
61,021
+17,697
| +41% | +$37.7K | ﹤0.01% | 5130 |
|
2024
Q4 | $138K | Buy |
43,324
+18,068
| +72% | +$57.6K | ﹤0.01% | 5233 |
|
2024
Q3 | $337K | Sell |
25,256
-53,404
| -68% | -$713K | ﹤0.01% | 4745 |
|
2024
Q2 | $784K | Buy |
78,660
+71,954
| +1,073% | +$717K | ﹤0.01% | 4003 |
|
2024
Q1 | $79.8K | Buy |
6,706
+5,405
| +415% | +$64.3K | ﹤0.01% | 5308 |
|
2023
Q4 | $5.23K | Sell |
1,301
-13,379
| -91% | -$53.8K | ﹤0.01% | 5595 |
|
2023
Q3 | $40.2K | Buy |
14,680
+13,458
| +1,101% | +$36.8K | ﹤0.01% | 4802 |
|
2023
Q2 | $8.16K | Buy |
+1,222
| New | +$8.16K | ﹤0.01% | 5152 |
|
2023
Q1 | – | Sell |
-4,944
| Closed | -$12.2K | – | 5627 |
|
2022
Q4 | $12.2K | Buy |
+4,944
| New | +$12.2K | ﹤0.01% | 5160 |
|
2022
Q3 | – | Sell |
-2,077
| Closed | -$6K | – | 5783 |
|
2022
Q2 | $6K | Buy |
2,077
+874
| +73% | +$2.53K | ﹤0.01% | 5318 |
|
2022
Q1 | $4K | Sell |
1,203
-3,032
| -72% | -$10.1K | ﹤0.01% | 5534 |
|
2021
Q4 | $16K | Buy |
+4,235
| New | +$16K | ﹤0.01% | 5129 |
|
2021
Q1 | – | Sell |
-2,472
| Closed | -$11K | – | 4975 |
|
2020
Q4 | $11K | Buy |
+2,472
| New | +$11K | ﹤0.01% | 3797 |
|